Searchable abstracts of presentations at key conferences in endocrinology

ea0092ps2-19-04 | Thyroid Hormone Transport & Metabolism Basic | ETA2023

Repositioning of cefuroxime as novel selective inhibitor of the thyroid hormone activating enzyme type 2 deiodinase

Miro Caterina , Sagliocchi Serena , Murolo Melania , Gaetana Cicatiello Annunziata , Nappi Annarita , Di Cicco Emery , Torabinejad Sepehr , Dentice Monica

The iodothyronine deiodinases constitute a family of three selenoenzymes regulating the intracellular metabolism of Thyroid Hormones (THs, T4 and T3) and impacting on several physiological processes, including energy metabolism, development and cell differentiation. The type 1, 2 and 3 deiodinases (D1, D2, and D3), are sensitive, rate-limiting components within the TH axis, and rapidly control TH action in physiological conditions or disease. Notably, several human pathologies...

ea0049ep153 | Endocrine tumours and neoplasia | ECE2017

Primary hepatic neuroendocrine tumor with multiple liver metastases treated with somatostatin analogues: case report

Golu Ioana , Balas Melania , Amzar Daniela , Cornianu Marioara , Vlad Mihaela

Introduction: Somatostatin analogues (SSA) have been used as first line treatment to control the symtoms in hormonally active neuroendocrine tumors (NET), for over three decades. Primary hepatic neuroendocrine tumors (PHNETs) are rare neoplasms. Despite increased incidence of PHNETs over time, these tumors remain a rarity. According to the previously reported cases, primary neuroendocrine carcinoma of the liver is usually multicentric, often mimicking liver metastases. The dem...

ea0035p893 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014

Post-partum pituitary insufficiency: diagnostic challenge

Amzar Daniela , Balas Melania , Golu Ioana , Vlad Mihaela , Zosin Ioana

Background: Postpartum hypopituitarism, known as Sheehan’s syndrome, occurs during a complicated childbirth, due to severe hemorrhage and hpovolemic shock that lead to ischemic necrosis of the pituitary gland.The aim of the study is to point out the clinical features in postpartum pituitary necrosis, so that the disease could be recognize rapidly, to present a laboratory work-up for a postive diagnosis, and also to describe the com...

ea0035p1016 | Thyroid (non-cancer) | ECE2014

Different therapeutic outcomes in two cases with active moderate-to-severe Graves'orbitopathy treated with intravenous steroid therapy-case presentation

Zosin Ioana , Vlad Mihaela , Balas Melania , Bolintineanu Carmen

Background: Graves’ orbitopathy (GO) comprises mild, moderate-to-severe and severe forms. The treatment is complex, depending on the activity and severity of the disease. Patients with active moderate-to-severe GO benefit by correction of thyrotoxicosis and glucocorticoids (GC), as first-line agents. Approximately 20-40% of cases are not responsive to GC therapy.Case presentations: There are presented two cases with active moderate-to-severe GO trea...

ea0026p293 | Pituitary | ECE2011

Prevalence of sleep apnea sindrome (SAS) in patients with acromegaly

Amzar Daniela , Mihaicuta Stefan , Golu Ioana , Balas Melania , Vlad Mihaela

Sleep apnea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. Consequences of SAS are serious and are associated with increased morbidity and mortality.The present study evaluates clinical aspects in acromegalic patients with sleep apnea syndrome (SAS), diagnosed and followed-up in the Clinic of Endocrinology, Timisoara, in the period 2007–2010. All the cases were confirmed and investi...

ea0022p590 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Sleeping apnea syndrome (SAS) in acromegaly and obesity

Amzar Daniela , Mihaicuta Stefan , Golu Ioana , Balas Melania , Zosin Ioana

The aim of the study: Acromegaly is associated with respiratory and cardiovascular morbidities and high mortality rate. The present study evaluates clinical aspects in acromegalic and obese patients with sleep apnea syndrome (SAS).Material and method: The patients were diagnosed and followed-up in the Clinic of Endocrinology, Timisoara, in the period 2006–2009. All the cases were confirmed and investigated as present guidelines recommend. The polyso...

ea0016p751 | Thyroid | ECE2008

Same aspects regarding immunohistochemical diagnosis of papillary thyroid carcinoma

Zosin Ioana , Golu Ioana , Cornianu Marioara , Amzar Daniela , Balas Melania

The study evaluates the expression of same immunohistochemical (IHC) markers (Ki-67, PCNA, CK-19, HBME-1 and Galectin 3, in the diagnosis of differentiated thyroid carcinomas.Material and methods: The study group comprised 57 patients with thyroid tumors; aged 17–71 years (mean age 48.96 years). All cases were evaluated before surgical treatment by means of clinical examination, thyroid ultrasonography and fine needle aspiration biopsy (FNAB).<p...

ea0014p335 | (1) | ECE2007

Usefulness of Ki-67, PCNA, c-erbB-2 and CK 19 in the diagnosis of some thyroid follicular tumors

Zosin Ioana , Cornianu Marioara , Golu Ioana , Balas Melania , Milos Aurora

This study represents a complex evaluation of a group of 26 cases with thyroid nodular disease (TND), using different diagnostic methods. Clinically and by means of ultrasonography, 12 patients were suspected of malignancy. Fine-needle aspiration biopsy (FNAB) detected mainly suspicious (12 cases) and malignant smears (5 cases). The microscopic examination of surgical specimens established the following diagnosis: follicular adenoma – FA (4 cases), papillary hyperplasia &...

ea0073aep550 | Pituitary and Neuroendocrinology | ECE2021

Improvements in quality of life after treatment in three acromegalic patients

Plotuna Iulia-Ştefania , Vlad Mihaela , Balas Melania

Acromegaly is a rare disease. In more than 99% of cases this is due to a benign pituitary growth-hormone secreting adenoma. This leads to changes in appearance, enlargement of the internal organs and, after a long period of time, to multiple comorbidities.ObjectivesTo determine which factors might have contributed to the lower quality of life in three acromegalic patients.Materials and methods<p class="ab...

ea0032p681 | Neuroendocrinology | ECE2013

Hypothalamic melanin-concentrating hormone influences liver and adipose lipid metabolism

Imbernon Monica , Beiroa Daniel , Vazquez Maria J , Morgan Donald A , Veyrat-Durebex Christelle , Porteiro Begona , Diaz-Arteaga Adenis , Senra Ana , Al-Massadi Omar , Velasquez Douglas A , Gallego Rosalia , Seoane Luisa M , Lopez Miguel , Davis Roger J , Sabio Guadalupe , Rohner-Jeanrenaud Francoise , Rahmouni Kamal , Dieguez Carlos , Nogueiras Ruben

Introduction: Melanin-concentrating hormone (MCH) is an orexigenic neuropeptide which is located in the lateral hypothalamus and regulate the energy balance. MCH deficient mice are hypophagic, lean and do not develop hepatosteatosis when fed on high fat diet. The MCH increases food intake and adiposity, so we sought to investigate the role of the MCH on adipocyte and hepatic metabolism.Methods: MCH were chronically administered into the lateral ventricle...